Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics - Current status and future prospects

European Journal of Cancer

Volumn 41, Issue 7, 2005, Pages 971-979

  Kelland, Lloyd R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7 TRICHLORO 5 NITROQUINOXALINE; 2,6 DIAMIDOANTHRAQUINONE; ACRIDINE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; BIBR 1532; BRACO 19; DIBENZOPHENANTHROLINE; ETHIDIUM; GRN 163; GRN 163L; LIPOFECTAMINE; NUCLEOTIDE DERIVATIVE; OLIGONUCLEOTIDE; PACLITAXEL; PHENANTHROLINE DERIVATIVE; PHENOXAZINE DERIVATIVE; PORPHYRIN DERIVATIVE; QQ 58; QUINOXALINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SINGLE STRANDED DNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMESTATIN; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CELL DIVISION; CELL IMMORTALIZATION; CELL LINE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; DNA STRUCTURE; DRUG EFFICACY; DRUG POTENCY; DRUG TARGETING; ENZYME INHIBITION; ENZYME REACTIVATION; GENETICS; HUMAN; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; REVIEW; SENESCENCE; TELOMERE; TUMOR CELL; XENOGRAFT;

EID: 18044391665     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.11.024     Document Type: Article

References (87)

1. S. Neidle, and L.R. Kelland Telomerase as an anti-cancer target: current status and future prospects Anti-Cancer Drug Des 14 1999 341 347
2. N.W. Kim, M.A. Piatyszek, and K.R. Prowse Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
3. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
4. A. Smogorzewska, and T. de Lange Regulation of telomerase by telomeric proteins Annu Rev Biochem 73 2004 177 208
5. G.Z. Li, M.S. Eller, and R. Firoozabadi Evidence that exposure of the telomere 3′ overhang sequence induces senescence PNAS 100 2003 527 531
6. P. Baumann, and T.R. Cech Pot1, the putative telomere end-binding protein in fission yeast and humans Science 292 2001 1171 1175
7. J.D. Griffith, L. Comeau, and S. Rosenfield Mammalian telomeres end in a large duplex loop Cell 97 1999 503 514
8. G.B. Morin The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats Cell 59 1989 521 529
9. J. Feng, W.D. Funk, and S.-S. Wang The RNA component of human telomerase Science 269 1995 1236 1240
10. T.M. Nakamura, G.B. Morin, and K.B. Chapman Telomerase catalytic subunit homologs from fission yeast and human Science 277 1997 955 959
11. W.C. Hahn, C.M. Counter, and A.S. Lundberg Creation of human tumour cells with defined genetic elements Nature 400 1999 464 468
12. S.A. Stewart, W.C. Hahn, and B.F. O'Connor Telomerase contributes to tumorigenesis by a telomere length-independent mechanism Proc Natl Acad Sci 99 2002 12606 12611
13. A.G. Bodnar, M. Ouellette, and M. Frolkis Extension of life-span by introduction of telomerase into normal human cells Science 279 1998 349 352
14. J.A. Londono-Vallejo, H. Der-Sarkissian, and L. Cazes Alternative lengthening of telomeres is characterized by high rates of telomeric exchange Cancer Res 64 2004 2324 2327
15. M.A. Dunham, A.A. Neumann, and C.L. Fasching Telomere maintenance by recombination in human cells Nat Genet 26 2000 447 450
16. G.A. Ulaner, A.R. Hoffman, and J. Otero Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas Gene Chromosome Canc 41 2004 155 162
17. V. Hakin-Smith, D.A. Jellinek, and D. Levy Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme Lancet 361 2003 836 838
18. D. Broccoli, J.W. Young, and T. Lange de Telomerase activity in normal and malignant hematopoietic cells Proc Natl Acad Sci 92 1995 9082 9086
19. C. Harle-Bachor, and P. Boukamp Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes Proc Natl Acad Sci 93 1996 6476 6481
20. K. Masutomi, E.Y. Yu, and S. Khurts Telomerase maintains telomere structure in normal human cells Cell 114 2003 241 253
21. A.K. Meeker, J.L. Hicks, and E.A. Platz Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis Cancer Res 62 2002 6405 6409
22. N.T. van Heek, A.K. Meeker, and S.E. Kern Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia Am J Pathol 161 2002 1541 1547
23. A.K. Meeker, J.L. Hicks, and E. Gabrielson Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma Am J Pathol 164 2004 925 935
24. H.W. Lee, M.A. Blasco, and G.J. Gottlieb Essential role of mouse telomerase in highly proliferative organs Nat Med 392 1998 569 574
25. W.C. Hahn, S.A. Stewart, and M.W. Brooks Inhibition of telomerase limits the growth of human cancer cells Nat Med 5 1999 1164 1170
26. X. Zhang, V. Mar, and W. Zhou Telomere shortening and apoptosis in telomerase-inhibited human tumor cells Gene Develop 13 1999 2388 2399
27. B.S. Herbert, A.E. Pitts, and S.I. Baker Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death PNAS 96 1999 14276 14281
28. G. Saretzki, A. Ludwig, and T. von Zglinicki Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells Cancer Gene Therap 8 2001 827 834
29. K. Kraemer, S. Fuessel, and U. Schmidt Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells Clin Cancer Res 9 2003 3794 3800
30. L. Marusic, M. Anton, and A. Tidy Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability Mol Cell Biol 17 1997 6394 6401
31. C. Guiducci, M.A. Cerone, and S. Bacchetti Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability Oncogene 20 2001 714 725
32. M.M. Kim, M.A. Rivera, and I.N. Botchkina A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation PNAS 98 2001 7982 7987
33. S. Li, J.E. Rosenberg, and A.A. Donjacour Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA Cancer Res 64 2004 4833 4840
34. S.E. Holt, D.L. Aisner, and J. Baur Functional requirement of p23 and HSP90 in telomerase complexes Gene Develop 13 1999 817 826
35. H. Nishi, T. Nakada, and S. Kyo Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT) Mol Cell Biol 24 2004 6076 6083
36. M. Akiyama, T. Hideshima, and T. Hayashi Nuclear factor kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein Cancer Res 63 2003 18 21
37. D.C. Nguyen, and D.L. Crowe Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity Biochim Biophys Acta 1445 1999 207 215
38. C. Strahl, and E.H. Blackburn The effects of nucleoside analogs on telomerase and telomeres in tetrahymena Nucleic Acids Res 22 1994 893 900
39. K. Damm, U. Hemmann, and P. Garin-Chesa A highly selective telomerase inhibitor limiting human cancer cell proliferation EMBO J 20 2001 6958 6968
40. E. Pascolo, C. Wenz, and J. Lingner Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate J Biol Chem 277 2002 15566 15572
41. J.H. Kim, J.H. Kim, and G.E. Lee Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells Biochem Soc 373 2003 523 529
42. B.S. Herbert, K. Pongracz, and J.W. Shay Oligonucleotide N3′ → P5′ phosphoramidates as efficient telomerase inhibitors Oncogene 21 2002 638 642
43. A. Asai, Y. Oshima, and Y. Yamamoto A novel telomerase template antagonist (GRN163) as a potential anticancer agent Cancer Res 63 2003 3931 3939
44. M. Akiyama, T. Hideshima, and M.A. Shammas Effects of oligonucleotide N3′-P5′ thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells Cancer Res 63 2003 6187 6194
45. E.S. Wang, K. Wu, and A.C. Chin Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma Blood 103 2004 258 266
46. T. Ozawa, S.M. Gryaznov, and L.J. Hu Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts Neuro-oncology 6 2004 218 226
47. E.H. Blackburn Switching and signaling at the telomere Cell 106 2001 661 673
48. A.M. Zahler, J.R. Williamson, and T.R. Cech Inhibition of telomerase by G-quartet DNA structures Nature 350 1991 718 720
49. D. Sun, B. Thompson, and B.E. Cathers Inhibition of human telomerase by a G-quadruplex-interactive compound J Med Chem 40 1997 2113 2116
50. R.T. Wheelhouse, D. Sun, and H. Han Cationic porphyrins as telomerase inhibitors: the interaction of tetra-(N-methyl-4-pyridyl)porphine with quadruplex DNA J Am Chem Soc 120 1998 3261 3262
51. M.A. Read, J.R. Harrison, and B. Romagnoli Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors PNAS 98 2001 4844 4849
52. K. Shin-ya, K. Wierzba, and K.-I. Matsuo Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus J Am Chem Soc 123 2001 1262 1263
53. J.L. Mergny, L. Lacroix, and M.-P. Teulado-Fichou Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay Proc Natl Acad Sci 98 2001 3062 3067
54. F. Koeppel, J.F. Riou, and A. Laoui Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes Nucleic Acids Res 29 2001 1087 1096
55. J.F. Riou, L. Guittat, and P. Mailliet Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands PNAS 5 2002 2672 2677
56. S.M. Gowan, R. Heald, and M.F.G. Stevens Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes Mol Pharmacol 60 2001 981 988
57. W. Duan, A. Rangan, and H. Vankayalapati Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects Mol Cancer Therap 1 2001 103 120
58. R.J. Harrison, S.M. Gowan, and L.R. Kelland Human telomerase inhibition by substituted acridine derivatives Bioorg Med Chem Lett 9 1999 2463 2468
59. G.N. Parkinson, M.P.H. Lee, and S. Neidle Crystal structure of parallel quadruplexes from human telomeric DNA Nature 417 2002 876 880
60. C. Schaffitzel, I. Berger, and J. Postberg In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei PNAS 98 2001 8572 8577
61. C.C. Chang, I.C. Kuo, and I.-F. Ling Detection of quadruplex DNA structures in human telomeres by a fluorescent carbazole derivative Anal Chem 76 2004 4490 4494
62. S.A. Stewart, I. Ben-Porath, and V.J. Carey Erosion of the telomeric single-strand overhang at replicative senescence Nat Genet 4 2003 492 496
63. J. Karlseder, A. Smogorzewska, and T. de Lange Senescence induced by altered telomere state, not telomere loss Science 295 2002 2446 2449
64. C.M. Incles, C.M. Schultes, and H. Kempski A G-quadruplex telomere maintenance inhibitor produces p16-associated senescence and chromosomal fusions in human prostate cancer cells Mol Cancer Therap 3 2004 1201 1206
65. U. Herbig, W.A. Jobling, and B.P.C. Chen Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53 and p21CIP1, but not p16INK4a Mol Cell 14 2004 501 513
66. F. d'Adda dl Fagagna, P.M. Reaper, and L. Clay-Farrace A DNA damage checkpoint response in telomere-initiated senescence Nature 426 2003 194 198
67. C. Leonetti, S. Amodei, and C. D'Angelo Biological activity of the G-quadruplex ligand RHPS4 is associated with telomere capping alteration Mol Pharmacol 66 2004 1138 1146
68. D. Gomez, R. Paterski, and T. Lemarteleur Interaction of telomestatin with the telomeric single-strand overhang J Biol Chem 279 2004 41487 41494
69. D. Gomez, N. Aouali, and A. Renaud Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase Cancer Res 63 2003 6149 6153
70. M.Y. Kim, M. Gleason-Guzman, and E. Izbicka The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures Cancer Res 63 2003 3247 3256
71. A. Siddiqui-Jain, C.L. Grand, and D.J. Bearss Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription Proc Natl Acad Sci 99 2002 11593 11598
72. S.M. Gowan, J.R. Harrison, and L. Patterson A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity Mol Pharmacol 61 2002 1154 1162
73. A.M. Burger, F. Dai, and C.M. Schultes The b-Quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function Cancer Res 65 2005 1489 1496
74. C.L. Grand, H. Han, and R.B. Munoz The cationic porphyrin TMPyP4 down-regulates c-MYC and humnan telomerase transeriphase expression and inhibits tumor growth in vivo Mol Cancer Therap 1 2002 565 573
75. I.A. Sidorov, K.S. Hirsch, and C.B. Harley Cancer treatment by telomerase inhibitors: predictions by a kinetic model Math Biosci 181 2003 209 221
76. K.H. Lee, K.L. Rudolph, and Y.J. Ju Telomere dysfunction alters the chemotherapeutic profile of transformed cells PNAS 98 2001 3381 3386
77. L.R. Kelland "Of mice and men": values and liabilities of the athymic nude mouse model in anticancer drug development Eur J Cancer 40 2004 827 836
78. D. Kipling, and H.J. Cooke Hypervariable ultra-long telomeres in mice Nature 347 1990 400 402
79. G.M. Coviello-McLaughlin, and K.R. Prowse Telomere length regulation during postnatal development and ageing in Mus spretus Nucleic Acids Res 25 1997 3051 3058
80. V.L. Makarov, S. Lejnine, and J. Bedoyan Nucleosomal organization of telomere-specific chromatin in rat Cell 73 1993 775 787
81. L. Nasir, P. Devlin, and T. McKevitt Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology Neoplasia 3 2001 351 359
82. W.W. Lee, K.H. Nam, and K. Terao Age-related telomere length dynamics in peripheral blood mononuclear cells of healthy cynomolgus monkeys measured by Flow FISH Immunology 105 2002 458 465
83. R.K. Moyzis, J.M. Buckingham, and L.S. Cram A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes Proc Natl Acad Sci 85 1988 6622 6626
84. H. Vaziri, W. Dragowska, and R.C. Allsopp Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age Proc Natl Acad Sci 91 1994 9857 9860
85. C.T. Chu, M.A. Piatyszek, and S.S.Y. Wong Telomerase activity and telomere lengths in the NCI cell panel of human cancer cell lines Proc Am Assoc Cancer Res 41 2000 #3405
86. R. Gertler, R. Rosenberg, and D. Stricker Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma J Clin Oncol 10 2004 1807 1814
87. K.D. Wu, L.M. Orme, and J. Shaughnessy Jr. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival Blood 101 2003 4982 4989